These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17885929)
1. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. Geier DA; Geier MR J Toxicol Environ Health A; 2007 Oct; 70(20):1723-30. PubMed ID: 17885929 [TBL] [Abstract][Full Text] [Related]
2. A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders. Geier DA; Kern JK; Geier MR J Toxicol Environ Health A; 2009; 72(24):1585-91. PubMed ID: 20077233 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of environmental toxicity and susceptibility in autism. Geier DA; Kern JK; Garver CR; Adams JB; Audhya T; Nataf R; Geier MR J Neurol Sci; 2009 May; 280(1-2):101-8. PubMed ID: 18817931 [TBL] [Abstract][Full Text] [Related]
4. An investigation of porphyrinuria in Australian children with autism. Austin DW; Shandley K J Toxicol Environ Health A; 2008; 71(20):1349-51. PubMed ID: 18704827 [TBL] [Abstract][Full Text] [Related]
5. A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production. Heyer NJ; Bittner AC; Echeverria D; Woods JS Toxicol Lett; 2006 Feb; 161(2):159-66. PubMed ID: 16214298 [TBL] [Abstract][Full Text] [Related]
6. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder. Kern JK; Geier DA; Adams JB; Geier MR Biometals; 2010 Dec; 23(6):1043-51. PubMed ID: 20532957 [TBL] [Abstract][Full Text] [Related]
7. Porphyrinuria in Korean children with autism: correlation with oxidative stress. Youn SI; Jin SH; Kim SH; Lim S J Toxicol Environ Health A; 2010; 73(10):701-10. PubMed ID: 20391113 [TBL] [Abstract][Full Text] [Related]
8. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Kern JK; Geier DA; Adams JB; Mehta JA; Grannemann BD; Geier MR Pediatr Int; 2011 Apr; 53(2):147-53. PubMed ID: 20626635 [TBL] [Abstract][Full Text] [Related]
9. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder. Khaled EM; Meguid NA; Bjørklund G; Gouda A; Bahary MH; Hashish A; Sallam NM; Chirumbolo S; El-Bana MA Metab Brain Dis; 2016 Dec; 31(6):1419-1426. PubMed ID: 27406246 [TBL] [Abstract][Full Text] [Related]
10. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Geier DA; Geier MR Neurotox Res; 2006 Aug; 10(1):57-64. PubMed ID: 17000470 [TBL] [Abstract][Full Text] [Related]
12. Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor. Woods JS; Martin MD; Naleway CA; Echeverria D J Toxicol Environ Health; 1993; 40(2-3):235-46. PubMed ID: 8230299 [TBL] [Abstract][Full Text] [Related]
13. Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins. Kern JK; Geier DA; Ayzac F; Adams JB; Mehta JA; Geier MR Toxicol Environ Chem; 2011 Feb; 93(1-2):396-405. PubMed ID: 24482554 [TBL] [Abstract][Full Text] [Related]
14. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Geier DA; Geier MR Neuro Endocrinol Lett; 2007 Oct; 28(5):565-73. PubMed ID: 17984958 [TBL] [Abstract][Full Text] [Related]
15. A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children's dental amalgam trial. Geier DA; Carmody T; Kern JK; King PG; Geier MR Biometals; 2011 Apr; 24(2):215-24. PubMed ID: 21053054 [TBL] [Abstract][Full Text] [Related]
16. Porphyrinuria in Autism Spectrum Disorder: A Review. Bjørklund G; Semenova Y; El-Ansary A; Al-Ayadhi LY Curr Med Chem; 2023 Nov; ():. PubMed ID: 38031776 [TBL] [Abstract][Full Text] [Related]
17. Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity. Woods JS Can J Physiol Pharmacol; 1996 Feb; 74(2):210-5. PubMed ID: 8723034 [TBL] [Abstract][Full Text] [Related]
18. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. Geier DA; Geier MR J Toxicol Environ Health A; 2007 May; 70(10):837-51. PubMed ID: 17454560 [TBL] [Abstract][Full Text] [Related]
19. The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Woods JS; Echeverria D; Heyer NJ; Simmonds PL; Wilkerson J; Farin FM Toxicol Appl Pharmacol; 2005 Aug; 206(2):113-20. PubMed ID: 15967199 [TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of porphyrins in rat and human urine and evaluation of urinary porphyrin profiles during mercury and lead exposures. Bowers MA; Aicher LD; Davis HA; Woods JS J Lab Clin Med; 1992 Aug; 120(2):272-81. PubMed ID: 1500825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]